Yes, Antipsychotics Cause Anticholinergic Side Effects
Antipsychotic medications do cause anticholinergic side effects, with significant variation between specific agents—low-potency typical antipsychotics (like chlorpromazine and thioridazine) and certain atypical antipsychotics (particularly clozapine, olanzapine, and quetiapine) have the most prominent anticholinergic activity, while high-potency typicals (like haloperidol) and some atypicals (aripiprazole, risperidone, ziprasidone) have minimal to no anticholinergic effects 1.
Understanding the Anticholinergic Profile by Agent
High Anticholinergic Activity
- Clozapine: Highest anticholinergic burden among all antipsychotics, with therapeutic doses producing 27-250 pmol/mL of atropine equivalents 2
- Low-potency typical antipsychotics (thioridazine, chlorpromazine): Significant anticholinergic effects including sedation and memory deficits 1
- Olanzapine: Moderate anticholinergic activity (1-15 pmol/mL atropine equivalents) 3, 2
- Quetiapine: Lower but present anticholinergic activity (0-5.4 pmol/mL atropine equivalents) 3, 2
Minimal to No Anticholinergic Activity
- High-potency typical antipsychotics (haloperidol, fluphenazine): Primarily cause extrapyramidal symptoms rather than anticholinergic effects 1
- Aripiprazole, risperidone, ziprasidone: No demonstrable anticholinergic activity at therapeutic concentrations 2
Common Anticholinergic Side Effects
The prevalence of anticholinergic symptoms is substantial across antipsychotic use:
- Blurred vision: 10-20% with newer atypicals (risperidone 11.9%, olanzapine 12.2%), similar to chlorpromazine (11.2%), but less than trifluoperazine (31.1%) 4
- Dry mouth: Occurs in 1-40% of patients depending on agent 5
- Constipation: Ranges from 1-41% across different antipsychotics 5
- Cognitive effects: Sedation, cognitive blunting, apathy, and memory deficits, particularly with agents having greater anticholinergic activity 1
Clinical Implications and Management
For Elderly Patients
Typical antipsychotics should be avoided in elderly patients when possible due to significant anticholinergic side effects involving the cholinergic, cardiovascular, and extrapyramidal systems 6. The anticholinergic burden is particularly problematic in older adults, associated with decline in cognition, functional status, and activities of daily living scores 7.
Monitoring Anticholinergic Burden
When managing patients on antipsychotics, review the total anticholinergic burden of the entire medication regimen and minimize it, especially in patients with cognitive symptoms 3. If positive symptoms are well controlled, consider gradual dose reduction while remaining within the therapeutic range 3.
Treatment Adjustments
For patients experiencing problematic anticholinergic effects:
- Switch to agents with lower anticholinergic activity (aripiprazole, risperidone, ziprasidone, or high-potency typicals like haloperidol if extrapyramidal symptoms are not a concern)
- Avoid adding anticholinergic medications (like benztropine or trihexyphenidyl) to treat extrapyramidal symptoms in elderly patients 6
- Consider dose reduction if clinically feasible 3
Important Caveats
The distinction between typical and atypical antipsychotics regarding anticholinergic effects is not as clear-cut as commonly believed. There is more variability among specific antipsychotic medications than between the first- and second-generation classes 8. Over medium- and long-term use, there are no statistically significant differences between typicals and atypicals in most anticholinergic side effects, with the exception that typical antipsychotics show higher prevalence of blurred vision in long-term use 5.
Anticholinergic effects can paradoxically worsen psychosis even at therapeutic doses, particularly when multiple anticholinergic agents are combined 9. This underscores the importance of minimizing anticholinergic burden rather than adding anticholinergic medications to counteract extrapyramidal symptoms.